Price difference as a predictor of the selection between brand name and generic statins in Japan

Osamu Takizawa, Hisashi Urushihara, Shiro Tanaka, Koji Kawakami

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: This study aimed to explore the predictors of the selection between brand name drug (BR) and generic drug (GE) and to clarify the quantitative relationship about selection. Methods: We identified "incident users" who dispensed statins between April 2008 and June 2011 in commercially databases consisted of dispensing claims databases (DCD) of out-of-hospital pharmacies and hospital claims databases (HCD) of in-house pharmacies in Japan. Predictors of the selection between BR and GE, including price difference (PD), the price of BR, their interaction and percent change of the price of GE relative to BR were explored by logistic regression using DCD and HCD separately. Results: We extracted records of 670 patients who have opportunity for selection both BR and GE. Logistic regression analysis demonstrated that PD, the price of BR, interaction between them, and prescriber affiliation were factors significantly associated with the selection in the DCD; logit (p)=9.735-0.251 × PD-0.071 × the price of BR + 0.002 × PD × the price of BR-1.816 × affiliation + 0.220 × gender - 0.008 × age + 0.038 ×. monthly medical fee. PD was inversely proportional to BR choice in DCD and lead to the opposite result in HCD. Numerical simulation of selection revealed that the quantitative relationships heavily depend on situations. Conclusions: PD and the price of BR are predictors of the selection between BR and GE interactively in out-of-hospital pharmacies, but not in in-house pharmacies of medical facilities. Results may support policies which increase the power of out-of-hospital pharmacies for selection.

Original languageEnglish
Pages (from-to)612-619
Number of pages8
JournalHealth Policy
Volume119
Issue number5
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Names
Japan
Generic Drugs
Pharmacies
Databases
Medical Fees
Logistic Models

Keywords

  • Brand name drugs
  • Claims database
  • Generic drugs
  • Logistic regression analysis
  • Out-of-hospital pharmacies
  • Price difference

ASJC Scopus subject areas

  • Health Policy

Cite this

Price difference as a predictor of the selection between brand name and generic statins in Japan. / Takizawa, Osamu; Urushihara, Hisashi; Tanaka, Shiro; Kawakami, Koji.

In: Health Policy, Vol. 119, No. 5, 2015, p. 612-619.

Research output: Contribution to journalArticle

Takizawa, Osamu ; Urushihara, Hisashi ; Tanaka, Shiro ; Kawakami, Koji. / Price difference as a predictor of the selection between brand name and generic statins in Japan. In: Health Policy. 2015 ; Vol. 119, No. 5. pp. 612-619.
@article{bba5d9858f284ccfb915d8224588b50a,
title = "Price difference as a predictor of the selection between brand name and generic statins in Japan",
abstract = "Objectives: This study aimed to explore the predictors of the selection between brand name drug (BR) and generic drug (GE) and to clarify the quantitative relationship about selection. Methods: We identified {"}incident users{"} who dispensed statins between April 2008 and June 2011 in commercially databases consisted of dispensing claims databases (DCD) of out-of-hospital pharmacies and hospital claims databases (HCD) of in-house pharmacies in Japan. Predictors of the selection between BR and GE, including price difference (PD), the price of BR, their interaction and percent change of the price of GE relative to BR were explored by logistic regression using DCD and HCD separately. Results: We extracted records of 670 patients who have opportunity for selection both BR and GE. Logistic regression analysis demonstrated that PD, the price of BR, interaction between them, and prescriber affiliation were factors significantly associated with the selection in the DCD; logit (p)=9.735-0.251 × PD-0.071 × the price of BR + 0.002 × PD × the price of BR-1.816 × affiliation + 0.220 × gender - 0.008 × age + 0.038 ×. monthly medical fee. PD was inversely proportional to BR choice in DCD and lead to the opposite result in HCD. Numerical simulation of selection revealed that the quantitative relationships heavily depend on situations. Conclusions: PD and the price of BR are predictors of the selection between BR and GE interactively in out-of-hospital pharmacies, but not in in-house pharmacies of medical facilities. Results may support policies which increase the power of out-of-hospital pharmacies for selection.",
keywords = "Brand name drugs, Claims database, Generic drugs, Logistic regression analysis, Out-of-hospital pharmacies, Price difference",
author = "Osamu Takizawa and Hisashi Urushihara and Shiro Tanaka and Koji Kawakami",
year = "2015",
doi = "10.1016/j.healthpol.2015.01.010",
language = "English",
volume = "119",
pages = "612--619",
journal = "Health Policy",
issn = "0168-8510",
publisher = "Elsevier Ireland Ltd",
number = "5",

}

TY - JOUR

T1 - Price difference as a predictor of the selection between brand name and generic statins in Japan

AU - Takizawa, Osamu

AU - Urushihara, Hisashi

AU - Tanaka, Shiro

AU - Kawakami, Koji

PY - 2015

Y1 - 2015

N2 - Objectives: This study aimed to explore the predictors of the selection between brand name drug (BR) and generic drug (GE) and to clarify the quantitative relationship about selection. Methods: We identified "incident users" who dispensed statins between April 2008 and June 2011 in commercially databases consisted of dispensing claims databases (DCD) of out-of-hospital pharmacies and hospital claims databases (HCD) of in-house pharmacies in Japan. Predictors of the selection between BR and GE, including price difference (PD), the price of BR, their interaction and percent change of the price of GE relative to BR were explored by logistic regression using DCD and HCD separately. Results: We extracted records of 670 patients who have opportunity for selection both BR and GE. Logistic regression analysis demonstrated that PD, the price of BR, interaction between them, and prescriber affiliation were factors significantly associated with the selection in the DCD; logit (p)=9.735-0.251 × PD-0.071 × the price of BR + 0.002 × PD × the price of BR-1.816 × affiliation + 0.220 × gender - 0.008 × age + 0.038 ×. monthly medical fee. PD was inversely proportional to BR choice in DCD and lead to the opposite result in HCD. Numerical simulation of selection revealed that the quantitative relationships heavily depend on situations. Conclusions: PD and the price of BR are predictors of the selection between BR and GE interactively in out-of-hospital pharmacies, but not in in-house pharmacies of medical facilities. Results may support policies which increase the power of out-of-hospital pharmacies for selection.

AB - Objectives: This study aimed to explore the predictors of the selection between brand name drug (BR) and generic drug (GE) and to clarify the quantitative relationship about selection. Methods: We identified "incident users" who dispensed statins between April 2008 and June 2011 in commercially databases consisted of dispensing claims databases (DCD) of out-of-hospital pharmacies and hospital claims databases (HCD) of in-house pharmacies in Japan. Predictors of the selection between BR and GE, including price difference (PD), the price of BR, their interaction and percent change of the price of GE relative to BR were explored by logistic regression using DCD and HCD separately. Results: We extracted records of 670 patients who have opportunity for selection both BR and GE. Logistic regression analysis demonstrated that PD, the price of BR, interaction between them, and prescriber affiliation were factors significantly associated with the selection in the DCD; logit (p)=9.735-0.251 × PD-0.071 × the price of BR + 0.002 × PD × the price of BR-1.816 × affiliation + 0.220 × gender - 0.008 × age + 0.038 ×. monthly medical fee. PD was inversely proportional to BR choice in DCD and lead to the opposite result in HCD. Numerical simulation of selection revealed that the quantitative relationships heavily depend on situations. Conclusions: PD and the price of BR are predictors of the selection between BR and GE interactively in out-of-hospital pharmacies, but not in in-house pharmacies of medical facilities. Results may support policies which increase the power of out-of-hospital pharmacies for selection.

KW - Brand name drugs

KW - Claims database

KW - Generic drugs

KW - Logistic regression analysis

KW - Out-of-hospital pharmacies

KW - Price difference

UR - http://www.scopus.com/inward/record.url?scp=84933670487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933670487&partnerID=8YFLogxK

U2 - 10.1016/j.healthpol.2015.01.010

DO - 10.1016/j.healthpol.2015.01.010

M3 - Article

VL - 119

SP - 612

EP - 619

JO - Health Policy

JF - Health Policy

SN - 0168-8510

IS - 5

ER -